Skin Analytics

Skin Analytics is a British healthtech company founded in 2012, based in Cambridge.

The company focuses on early detection of skin cancer through its AI-powered medical device, DERM (Deep Ensemble for the Recognition of Malignancy). This innovative tool analyzes smartphone images of skin lesions to identify malignant, pre-malignant, and benign conditions, including melanoma. DERM is notable for being the first AI medical device approved to make autonomous clinical decisions on skin cancer without human review, achieving a remarkable accuracy rate. The company aims to make early and accurate skin cancer diagnosis accessible to everyone, thereby reducing the financial burden on health systems. Skin Analytics collaborates with public health systems, private insurers, and healthcare providers, including the NHS, to enhance patient pathways and optimize skin cancer assessments. Their services include autonomous skin cancer assessment, AI-supported teledermatology, and the creation of digital skin histories for patients. With a growing presence in the UK and plans for expansion into the US, EU, and Australia, Skin Analytics is committed to improving patient outcomes and addressing healthcare challenges.